INAVOLISIB (GDC-0077, RG6114)

An investigational, selective PI3Kα-mutant inhibitor and degrader^1-3

Inavolisib is an investigational small molecule designed to selectively inhibit mutant PI3Kα¹

PI3Kα=phosphatidylinositol 3-kinase alpha.